2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Merit Medical's Embosphere Microspheres Gain FDA Indication for Prostatic Artery Embolization

June 22, 2017 -- Merit Medical Systems, Inc. announced that it has received 513(f)(2) (de novo) classification from the US Food and Drug Administration (FDA) to expand the ind…

Key Milestones Announced for Shockwave Medical's Lithoplasty System in Treatment of PAD

June 21, 2017 -- Shockwave Medical, Inc. announced two milestones for its Lithoplasty system for the treatment of calcified plaque in patients with peripheral artery disease (…

German Study Demonstrates Benefit of Embolic Protection for Carotid Stenting

June 20, 2017 -- An analysis of a German database evaluating carotid artery stenting procedures concluded that the use of an embolic protection device was independently associ…

SVS Elects New Leadership for 2017–2018

June 20, 2017 -- The Society for Vascular Surgery (SVS) announced the election of the 2017 -- 2018 leadership at the business meeting held during the SVS Vascular An…

Fresenius Vascular Care Changes Name to Azura

June 20, 2017 -- Fresenius Vascular Care announced its new name, Azura Vascular Care, as part of a strategic rebranding initiative. A phased rollout of the new brand across al…

Ekos Therapy for Postthrombotic Syndrome Evaluated in ACCESS PTS Study

June 16, 2017 -- BTG International announced that results of the ACCESS PTS trial were presented at the Society for Vascular Medicine's 28th annual scientific session…

Click here for more News coverage

Current Supplement

Sponsored by GORE & ASSOCIATES

Tackling Complex Cases in AV Access

Providing durable access in challenging presentations.

Current European Supplement

Sponsored by VASCUTEK LTD.

EVARlution

More options and more solutions to treat complex AAA anatomy.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $49.27  1.44%
AstraZeneca PLC $35.36  1.38%
Avinger $0.46  4.15%
Boston Scientific Corporation $27.86  -0.18%
Cardinal Health $78.75  1.64%
Cardiovascular Systems Inc. $30.80  -3.08%
CR Bard Inc. $315.98  0.31%
Edwards Lifesciences Corp. $118.53  -0.30%
Endologix Inc. $4.74  1.28%
Vascular Market Price  Change
Johnson and Johnson $136.05  0.85%
Lombard Medical, Inc. $0.50  -1.96%
Medtronic, Inc. $89.09  0.34%
Merit Medical Systems, Inc. $37.10  0.82%
Penumbra, Inc. $89.30  2.64%
Stryker $141.22  0.30%
Teleflex Inc. $204.35  0.44%
The Medicines Company $38.15  -1.75%
The Spectranetics Corporation $30.00  1.01%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.